Development of Nanofiber-based Biosensors

The pandemic raised awareness of point-of-care devices that could test people against the Covid-19 virus. Such devices help decrease the spreading of diseases and offer the possibility of a suitable treatment. The requirements consist of being rapid, simple, portable, and inexpensive. Electrochemical detection can improve the outcome of such devices by delivering the exact concentration of the tested analyte, which can positively impact the patient's treatment. Carbon nanofibers are attractive as a signal transduction interface for point-of-care devices due to their high electrical conductivity, large surface area, and high stability paired with low cost. Herein, a biosensor is developed consisting of carbon nanofibers as an electrochemical transducer for point-of-care applications